Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      USFDA rejects filing for Celgene MS drug, shares fall

      USFDA rejects filing for Celgene MS drug, shares fall

      Ruby Khatun Khatun2 March 2018 9:45 AM IST
      U.S. health regulators have rejected Celgene Corp’s application seeking approval of key multiple sclerosis drugs due to insufficient data, the company...
      DISMAL report: Fortis reports net loss for Sept, Dec quarters

      DISMAL report: Fortis reports net loss for Sept, Dec quarters

      Ruby Khatun Khatun2 March 2018 9:44 AM IST
      New Delhi: Fortis Healthcare reported a consolidated net loss of Rs 19.10 crore for the quarter ended December 2017 against a profit of Rs 453.29...
      Becton, Dickinson and Co appoints Pavan Mocherla as MD for India, South Asia

      Becton, Dickinson and Co appoints Pavan Mocherla as MD for India, South Asia

      Ruby Khatun Khatun2 March 2018 9:30 AM IST
      New Delhi: Global medical technology firm Becton, Dickinson and Company (BD) said it has appointed Pavan Mocherla as the new managing director for...
      NPPA fixes retail prices of 14 formulations, check out details

      NPPA fixes retail prices of 14 formulations, check out details

      Ruby Khatun Khatun1 March 2018 2:42 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Google partners Apollo Hospitals for Symptom Search

      Google partners Apollo Hospitals for Symptom Search

      Ruby Khatun Khatun1 March 2018 10:54 AM IST
      New Delhi: Tech giant Google has partnered with Apollo Hospitals to roll out a new feature Symptom Search to provide better search results to users...
      Cipla ties up with Roche to sell 2 cancer drugs in India

      Cipla ties up with Roche to sell 2 cancer drugs in India

      Ruby Khatun Khatun1 March 2018 10:35 AM IST
      New Delhi: Drug firm Cipla said it has entered into an agreement with Roche Pharma to promote and distribute the latter's cancer drugs in India.The...
      Medtronic launches first slimmest and smallest stent for small vessels patients

      Medtronic launches first slimmest and smallest stent for small vessels patients

      Ruby Khatun Khatun1 March 2018 10:15 AM IST
      DUBLIN: Designed specifically for small vessels, Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the...
      Roche wins EU approval for hemophilia drug Hemlibra

      Roche wins EU approval for hemophilia drug Hemlibra

      Ruby Khatun Khatun1 March 2018 10:00 AM IST
      ZURICH: Swiss group Roche said the European Commission has approved its drug Hemlibra for people with hemophilia A who have developed resistance to...
      US subpoenas Mallinckrodt for information on opioid painkillers

      US subpoenas Mallinckrodt for information on opioid painkillers

      Ruby Khatun Khatun1 March 2018 9:45 AM IST
      Pharmaceutical company Mallinckrodt Plc said it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to...
      Medical device maker Medartis plans Swiss IPO

      Medical device maker Medartis plans Swiss IPO

      Ruby Khatun Khatun1 March 2018 9:30 AM IST
      ZURICH: Medartis Holding AG, a medical device maker specializing in surgical bone repairs, plans to sell shares in an initial public offering (IPO) on...
      DoP rejects Biocon plea to review ceiling price of Trastuzumab injection

      DoP rejects Biocon plea to review ceiling price of Trastuzumab injection

      Ruby Khatun Khatun28 Feb 2018 5:31 PM IST
      The Department of Pharmaceuticals (DoP) has rejected a review petition filed by Biocon Limited against the price fixation of Trastuzumab Injection -...
      Hetero launches fixed dose combination drug for HIV in India

      Hetero launches fixed dose combination drug for HIV in India

      Ruby Khatun Khatun28 Feb 2018 10:30 AM IST
      New Delhi: Drug firm Hetero said it has launched generic anti-retroviral fixed-dose combination (FDC) of Emtricitabine (200mg) and Tenofovir...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok